Associations of schizophrenia risk genes ZNF804A and CACNA1C with schizotypy and modulation of attention in healthy subjects

Abel, 2010, Sex differences in schizophrenia, Int. Rev. Psychiatry, 22, 417, 10.3109/09540261.2010.515205 Alvarez-Moya, 2007, Exophenotypical profile of adolescents with sustained attention deficit: a 10-year follow-up study, Psychiatry Res., 153, 119, 10.1016/j.psychres.2006.12.021 Axelrod, 2001, Schizotypal personality questionnaire-brief: factor structure and convergent validity in inpatient adolescents, J. Personal. Disord., 15, 168, 10.1521/pedi.15.2.168.19219 Balog, 2011, ZNF804A may be associated with executive control of attention, Genes Brain Behav., 10, 223, 10.1111/j.1601-183X.2010.00657.x Barrantes-Vidal, 2015, The role of schizotypy in the study of the etiology of schizophrenia spectrum disorders, Schizophr. Bull., 41, S408, 10.1093/schbul/sbu191 Bhat, 2012, CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease, Prog. Neurobiol., 99, 1, 10.1016/j.pneurobio.2012.06.001 Breeze, 2011, Evidence of reduced selective attention in schizotypal personality disorder, J. Clin. Exp. Neuropsychol., 33, 776, 10.1080/13803395.2011.558495 Brickenkamp, 2002 Brosey, 2015, Schizotypy and clinical symptoms, cognitive function, and quality of life in individuals with a psychotic disorder, Schizophr. Res., 166, 92, 10.1016/j.schres.2015.04.038 de Castro-Catala, 2017, The genome-wide associated candidate gene ZNF804A and psychosis-proneness: evidence of sex-modulated association, PLoS One, 12, 10.1371/journal.pone.0185072 Chang, 2015, Second-generation PLINK: rising to the challenge of larger and richer datasets, Gigascience, 4, 7, 10.1186/s13742-015-0047-8 Chang, 2017, The schizophrenia risk gene ZNF804A: clinical associations, biological mechanisms and neuronal functions, Mol. Psychiatry, 22, 944, 10.1038/mp.2017.19 Chapman, 1994, Putatively psychosis-prone subjects 10 years later, J. Abnorm. Psychol., 103, 171, 10.1037/0021-843X.103.2.171 Chen, 2000, Sustained attention deficits as markers of genetic susceptibility to schizophrenia, Am. J. Med. Genet., 97, 52, 10.1002/(SICI)1096-8628(200021)97:1<52::AID-AJMG7>3.0.CO;2-6 Clarke, 2010, Aspects of observing and claiming allele flips in association studies, Genet. Epidemiol., 34, 266 Compton, 2009, An examination of the factorial structure of the schizotypal personality questionnaire-brief (SPQ-B) among undergraduate students, Schizophr. Res., 115, 286, 10.1016/j.schres.2009.04.012 Craddock, 2009, Psychosis genetics: modeling the relationship between schizophrenia, bipolar disorder, and mixed (or &quot;schizoaffective&quot;) psychoses, Schizophr. Bull., 35, 482, 10.1093/schbul/sbp020 Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013, Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis, Lancet, 381, 1371, 10.1016/S0140-6736(12)62129-1 Dedic, 2018, Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood, Mol. Psychiatry, 23, 533, 10.1038/mp.2017.133 Dietsche, 2014, The impact of a CACNA1C gene polymorphism on learning and hippocampal formation in healthy individuals: a diffusion tensor imaging study, Neuroimage, 89, 256, 10.1016/j.neuroimage.2013.11.030 Dodell-Feder, 2019, The network structure of schizotypal personality traits in a population-based sample, Schizophr. Res., 10.1016/j.schres.2019.01.046 Donohoe, 2011, ZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophrenia, Neuroimage, 54, 2132, 10.1016/j.neuroimage.2010.09.089 Elvevåg, 2000, Cognitive impairment in schizophrenia is the core of the disorder, Crit. Rev. Neurobiol., 14, 21, 10.1615/CritRevNeurobiol.v14.i1.10 Erk, 2010, Brain function in carriers of a genome-wide supported bipolar disorder variant, Arch. Gen. Psychiatry, 67, 803, 10.1001/archgenpsychiatry.2010.94 Esslinger, 2009, Neural mechanisms of a genome-wide supported psychosis variant, Science, 324, 605, 10.1126/science.1167768 Ettinger, U., Joober, R., DE Guzman, R., O'Driscoll, G.A., 2006. Schizotypy, attention deficit hyperactivity disorder, and dopamine genes. Psychiatry Clin. Neurosci. 60, 764–767. doi:https://doi.org/10.1111/j.1440-1819.2006.01594.x. Ettinger, 2015, Cognition and brain function in Schizotypy: a selective review, Schizophr. Bull., 41, S417, 10.1093/schbul/sbu190 Ferreira, 2008, Nat. Genet., 40, 1056, 10.1038/ng.209 Fink, 2014, Creativity and schizotypy from the neuroscience perspective, Cogn. Affect. Behav. Neurosci., 14, 378, 10.3758/s13415-013-0210-6 Fonseca-Pedrero, 2018, Brief assessment of schizotypal traits: a multinational study, Schizophr. Res., 197, 182, 10.1016/j.schres.2017.10.043 Fuggetta, 2015, An electrophysiological insight into visual attention mechanisms underlying schizotypy, Biol. Psychol., 109, 206, 10.1016/j.biopsycho.2015.06.007 Girgenti, 2012, ZNF804a regulates expression of the schizophrenia-associated genes PRSS16, COMT, PDE4B, and DRD2, PLoS One, 7, 10.1371/journal.pone.0032404 Godar, 2014, Gene-sex interactions in schizophrenia: focus on dopamine neurotransmission, Front. Behav. Neurosci., 8, 71, 10.3389/fnbeh.2014.00071 Gooding, 2005, Clinical status of at-risk individuals 5 years later: further validation of the psychometric high-risk strategy, J. Abnorm. Psychol., 114, 170, 10.1037/0021-843X.114.1.170 Gooding, 2006, Sustained attention deficits in relation to psychometrically identified schizotypy: evaluating a potential endophenotypic marker, Schizophr. Res., 82, 27, 10.1016/j.schres.2005.11.015 Grant, 2014, Psychosis-proneness correlates with expression levels of dopaminergic genes, Eur. Psychiatry, 29, 304, 10.1016/j.eurpsy.2013.12.002 Guella, 2014, Allelic imbalance associated with the schizophrenia risk SNP rs1344706 indicates a cis-acting variant in ZNF804A, Schizophr. Res., 153, 243, 10.1016/j.schres.2014.01.005 Hargreaves, 2012, ZNF804A and social cognition in patients with schizophrenia and healthy controls, Mol. Psychiatry, 17, 118, 10.1038/mp.2011.102 Hatzimanolis, 2018, Stress-dependent association between polygenic risk for schizophrenia and schizotypal traits in young army recruits, Schizophr. Bull., 44, 338, 10.1093/schbul/sbx074 Hayes, 2013 Heilbronner, 2015, A common risk variant in CACNA1C supports a sex-dependent effect on longitudinal functioning and functional recovery from episodes of schizophrenia-spectrum but not bipolar disorder, Eur. Neuropsychopharmacol., 25, 2262, 10.1016/j.euroneuro.2015.09.012 Hill, 2011, Allelic differences in nuclear protein binding at a genome-wide significant risk variant for schizophrenia in ZNF804A, Mol. Psychiatry, 16, 787, 10.1038/mp.2011.21 Hill, 2012, Evidence that schizophrenia risk variation in the ZNF804A gene exerts its effects during fetal brain development, Am. J. Psychiatry, 169, 1301, 10.1176/appi.ajp.2012.11121845 Hill, 2008, Neurocognitive allied phenotypes for schizophrenia and bipolar disorder, Schizophr. Bull., 34, 743, 10.1093/schbul/sbn027 Holm, 1979, A simple sequentially Rejective multiple test procedure, Scand. J. Stat. Howes, 2009, The dopamine hypothesis of schizophrenia: version III--the final common pathway, Schizophr. Bull., 35, 549, 10.1093/schbul/sbp006 Jiang, 2015, Evaluating the association between CACNA1C rs1006737 and schizophrenia risk: a meta-analysis, Asia Pac. Psychiatry, 7, 260, 10.1111/appy.12173 Jones, 2016, Phenotypic manifestation of genetic risk for schizophrenia during adolescence in the general population, JAMA Psychiat., 73, 221, 10.1001/jamapsychiatry.2015.3058 Kircher, 2018, Neurobiology of the major psychoses: a translational perspective on brain structure and function-the FOR2107 consortium, Eur. Arch. Psychiatry Clin. Neurosci. Klein, 1997, Erfassung der schizotypen Persönlichkeit nach DSM-II-R: Psychometrische Eigenschaften einer autorisierten deutschsprachigen Übersetzung des “Schizotypal Personality Questionnaire” (SPQ) von Raine, Diagnostica, 43, 347 Klein, 2001, Konstruktvalidierung der deutschsprachigen Adaptation des Schizotypal Personality Questionnaires (SPQ) von Raine (1991), 349 Kremen, 1998, Sex differences in self-reported schizotypal traits in relatives of schizophrenic probands, Schizophr. Res., 34, 27, 10.1016/S0920-9964(98)00081-4 Krug, 2014, A genome-wide supported variant in CACNA1C influences hippocampal activation during episodic memory encoding and retrieval, Eur. Arch. Psychiatry Clin. Neurosci., 264, 103, 10.1007/s00406-013-0428-x Kwapil, 2013, Prediction of psychopathology and functional impairment by positive and negative schizotypy in the Chapmans' ten-year longitudinal study, J. Abnorm. Psychol., 122, 807, 10.1037/a0033759 Lee, 2017, Test–retest reliability and minimal detectable change of the D2 test of attention in patients with schizophrenia, Arch. Clin. Neuropsychol., 19 Lehrl, 1995 Lencz, 2010, A schizophrenia risk gene, ZNF804A, influences neuroanatomical and neurocognitive phenotypes, Neuropsychopharmacology, 35, 2284, 10.1038/npp.2010.102 Lufi, 2015, The effect of age on attention level, Int. J. Aging Hum. Dev., 81, 176, 10.1177/0091415015614953 Machiela, 2015, LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants, Bioinformatics, 31, 3555, 10.1093/bioinformatics/btv402 Mohr, 2015, Schizotypy - do not worry, it is not all worrisome, Schizophr. Bull., 41, 436, 10.1093/schbul/sbu185 Mohr, 2014, An overview of the association between Schizotypy and dopamine, Front. Psychiatry, 5, 10.3389/fpsyt.2014.00184 Moon, 2018, CACNA1C: association with psychiatric disorders, behavior, and neurogenesis, Schizophr. Bull., 44, 958, 10.1093/schbul/sby096 Moreno-Samaniego, 2017, Schizotypal traits and cognitive performance in siblings of patients with psychosis, Psychiatry Res., 258, 551, 10.1016/j.psychres.2017.09.007 Nenadic, 2015, ZNF804A genetic variation (rs1344706) affects brain grey but not white matter in schizophrenia and healthy subjects, Psychol. Med., 45, 143, 10.1017/S0033291714001159 Nettle, 2006, Schizotypy, creativity and mating success in humans, Proc. R. Soc. B Biol. Sci., 273, 611, 10.1098/rspb.2005.3349 Nieratschker, 2015, CACNA1C risk variant affects facial emotion recognition in healthy individuals, Sci. Rep., 5, 10.1038/srep17349 Nuechterlein, 2004, Identification of separable cognitive factors in schizophrenia, Schizophr. Res., 72, 29, 10.1016/j.schres.2004.09.007 O'Donovan, 2008, Identification of loci associated with schizophrenia by genome-wide association and follow-up, Nat. Genet., 40, 1053, 10.1038/ng.201 Pardiñas, A.F., Holmans, P., Pocklington, A.J., Escott-Price, V., Ripke, S., Carrera, N., Legge, S.E., Bishop, S., Cameron, D., Hamshere, M.L., Han, J., Hubbard, L., Lynham, A., Mantripragada, K., Rees, E., MacCabe, J.H., McCarroll, S.A., Baune, B.T., Breen, G., Byrne, E.M., Dannlowski, U., Eley, T.C., Hayward, C., Martin, N.G., McIntosh, A.M., Plomin, R., Porteous, D.J., Wray, N.R., Caballero, A., Geschwind, D.H., Huckins, L.M., Ruderfer, D.M., Santiago, E., Sklar, P., Stahl, E.A., Won, H., Agerbo, E., Als, T.D., Andreassen, O.A., Bækvad-Hansen, M., Mortensen, P.B., Pedersen, C.B., Børglum, A.D., Bybjerg-Grauholm, J., Djurovic, S., Durmishi, N., Pedersen, M.G., Golimbet, V., Grove, J., Hougaard, D.M., Mattheisen, M., Molden, E., Mors, O., Nordentoft, M., Pejovic-Milovancevic, M., Sigurdsson, E., Silagadze, T., Hansen, C.S., Stefansson, K., Stefansson, H., Steinberg, S., Tosato, S., Werge, T., GERAD1 Consortium: D.A., CRESTAR Consortium:, D. Collier, D.A. Rujescu, D. Kirov, G. Owen, M.J. O'Donovan, M.C. Walters, J.T.R., GERAD1 Consortium, CRESTAR Consortium, GERAD1 Consortium, CRESTAR Consortium, 2018. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat. Genet. 50, 381–389. doi: https://doi.org/10.1038/s41588-018-0059-2. Paulus, 2013, Partial support for ZNF804A genotype-dependent alterations in prefrontal connectivity, Hum. Brain Mapp., 34, 304, 10.1002/hbm.21434 Purcell, S., Chang, C., n.d. PLINK v1.9. R Core Team, 2018 Raine, 1991, The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria, Schizophr. Bull., 17, 555, 10.1093/schbul/17.4.555 Raine, 1992, Sex differences in schizotypal personality in a nonclinical population, J. Abnorm. Psychol., 101, 361, 10.1037/0021-843X.101.2.361 Raine, 1995, The SPQ-B: a brief screening instrument for schizotypal personality disorder, J. Personal. Disord., 9, 346, 10.1521/pedi.1995.9.4.346 Riley, 2010, Replication of association between schizophrenia and ZNF804A in the Irish case-control study of schizophrenia sample, Mol. Psychiatry, 15, 29, 10.1038/mp.2009.109 Ripke, S., O'Dushlaine, C., Chambert, K., Moran, J.L., Kähler, A.K., Akterin, S., Bergen, S.E., Collins, A.L., Crowley, J.J., Fromer, M., Kim, Y., Lee, S.H., Magnusson, P.K.E., Sanchez, N., Stahl, E.A., Williams, S., Wray, N.R., Xia, K., Bettella, F., Borglum, A.D., Bulik-Sullivan, B.K., Cormican, P., Craddock, N., de Leeuw, C., Durmishi, N., Gill, M., Golimbet, V., Hamshere, M.L., Holmans, P., Hougaard, D.M., Kendler, K.S., Lin, K., Morris, D.W., Mors, O., Mortensen, P.B., Neale, B.M., O'Neill, F.A., Owen, M.J., Milovancevic, M.P., Posthuma, D., Powell, J., Richards, A.L., Riley, B.P., Ruderfer, D., Rujescu, D., Sigurdsson, E., Silagadze, T., Smit, A.B., Stefansson, H., Steinberg, S., Suvisaari, J., Tosato, S., Verhage, M., Walters, J.T., Bramon, E., Corvin, A.P., O'Donovan, M.C., Stefansson, K., Scolnick, E., Purcell, S., McCarroll, S.A., Sklar, P., Hultman, C.M., Sullivan, P.F., Schwab, S.G., Wildenauer, D.B., Dudbridge, F., Holmans, P., Shi, J., Albus, M., Alexander, M., Campion, D., Cohen, D., Dikeos, D., Duan, J., Eichhammer, P., Godard, S., Hansen, M., Lerer, F.B., Liang, K.-Y., Maier, W., Mallet, J., Nertney, D.A., Nestadt, G., Norton, N., O'Neill, F.A., Papadimitriou, G.N., Ribble, R., Sanders, A.R., Silverman, J.M., Walsh, D., Williams, N.M., Wormley, B., Psychosis Endophenotypes International Consortium, Arranz, M.J., Bakker, S., Bender, S., Bramon, E., Collier, D., Crespo-Facorro, B., Hall, J., Iyegbe, C., Jablensky, A., Kahn, R.S., Kalaydjieva, L., Lawrie, S., Lewis, C.M., Lin, K., Linszen, D.H., Mata, I., McIntosh, A., Murray, R.M., Ophoff, R.A., Powell, J., Rujescu, D., Van Os, J., Walshe, M., Weisbrod, M., Wiersma, D., Wellcome Trust Case Control Consortium 2, Donnelly, P., Barroso, I., Blackwell, J.M., Bramon, E., Brown, M.A., Casas, J.P., Corvin, A.P., Deloukas, P., Duncanson, A., Jankowski, J., Markus, H.S., Mathew, C.G., Palmer, C.N.A., Plomin, R., Rautanen, A., Sawcer, S.J., Trembath, R.C., Viswanathan, A.C., Wood, N.W., Spencer, C.C.A., Band, G., Bellenguez, C., Freeman, C., Hellenthal, G., Giannoulatou, E., Pirinen, M., Pearson, R.D., Strange, A., Su, Z., Vukcevic, D., Donnelly, P., Langford, C., Hunt, S.E., Edkins, S., Gwilliam, R., Blackburn, H., Bumpstead, S.J., Dronov, S., Gillman, M., Gray, E., Hammond, N., Jayakumar, A., McCann, O.T., Liddle, J., Potter, S.C., Ravindrarajah, R., Ricketts, M., Tashakkori-Ghanbaria, A., Waller, M.J., Weston, P., Widaa, S., Whittaker, P., Barroso, I., Deloukas, P., Mathew, C.G., Blackwell, J.M., Brown, M.A., Corvin, A.P., McCarthy, M.I., Spencer, C.C.A., Bramon, E., Corvin, A.P., O'Donovan, M.C., Stefansson, K., Scolnick, E., Purcell, S., McCarroll, S.A., Sklar, P., Hultman, C.M., Sullivan, P.F., 2013. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 45, 1150–1159. doi:https://doi.org/10.1038/ng.2742. Roussos, 2011, The CACNA1C and ANK3 risk alleles impact on affective personality traits and startle reactivity but not on cognition or gating in healthy males, Bipolar Disord., 13, 250, 10.1111/j.1399-5618.2011.00924.x Roussos, 2013, CACNA1C as a risk factor for schizotypal personality disorder and schizotypy in healthy individuals, Psychiatry Res., 206, 122, 10.1016/j.psychres.2012.08.039 Ruderfer, 2014, Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia, Mol. Psychiatry, 19, 1017, 10.1038/mp.2013.138 Schultz, 2014, ZNF804A and cortical structure in schizophrenia: in vivo and postmortem studies, Schizophr. Bull., 40, 532, 10.1093/schbul/sbt123 Sheldrick, 2008, Effect of COMT val158met genotype on cognition and personality, Eur. Psychiatry, 23, 385, 10.1016/j.eurpsy.2008.05.002 Siddi, 2017, Neuropsychological correlates of schizotypy: a systematic review and meta-analysis of cross-sectional studies, Cogn. Neuropsychiatry, 22, 186, 10.1080/13546805.2017.1299702 Smyrnis, 2007, Effect of schizotypy on cognitive performance and its tuning by COMT val158 met genotype variations in a large population of young men, Biol. Psychiatry, 61, 845, 10.1016/j.biopsych.2006.07.019 Snitz, 2005, Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes, Schizophr. Bull., 32, 179, 10.1093/schbul/sbi048 Soeiro-de-Souza, 2012, The impact of the CACNA1C risk allele on limbic structures and facial emotions recognition in bipolar disorder subjects and healthy controls, J. Affect. Disord., 141, 94, 10.1016/j.jad.2012.03.014 Stefanis, 2013, Variation in psychosis gene ZNF804A is associated with a refined schizotypy phenotype but not neurocognitive performance in a large young male population, Schizophr. Bull., 39, 1252, 10.1093/schbul/sbs110 Stotesbury, 2018, The influence of schizotypal traits on attention under high perceptual load, Schizophr. Res. Cogn., 11, 6, 10.1016/j.scog.2017.10.002 Strohmaier, 2013, The psychiatric vulnerability gene CACNA1C and its sex-specific relationship with personality traits, resilience factors and depressive symptoms in the general population, Mol. Psychiatry, 18, 607, 10.1038/mp.2012.53 Sun, 2015, Association between variants of zinc finger genes and psychiatric disorders: systematic review and meta-analysis, Schizophr. Res., 162, 124, 10.1016/j.schres.2015.01.036 Tesli, 2013, CACNA1C risk variant and amygdala activity in bipolar disorder, schizophrenia and healthy controls, PLoS One, 8, 10.1371/annotation/3b96507c-056e-4317-8234-de84b2b8113b Thimm, 2011, Effects of a CACNA1C genotype on attention networks in healthy individuals, Psychol. Med., 41, 1551, 10.1017/S0033291710002217 Toulopoulou, 2007, Substantial genetic overlap between neurocognition and schizophrenia, Arch. Gen. Psychiatry, 64, 1348, 10.1001/archpsyc.64.12.1348 Toulopoulou, 2015, Reciprocal causation models of cognitive vs volumetric cerebral intermediate phenotypes for schizophrenia in a pan-European twin cohort, Mol. Psychiatry, 20, 1386, 10.1038/mp.2014.152 Toulopoulou, 2018, Polygenic risk score increases schizophrenia liability through cognition-relevant pathways, Brain, 1 Van Den Bossche, 2012, Less cognitive and neurological deficits in schizophrenia patients carrying risk variant in ZNF804A, Neuropsychobiology, 66, 158, 10.1159/000339731 Voineskos, 2011, The ZNF804A gene: characterization of a novel neural risk mechanism for the major psychoses, Neuropsychopharmacology, 36, 1871, 10.1038/npp.2011.72 Walters, 2010, Psychosis susceptibility gene ZNF804A and cognitive performance in schizophrenia, Arch. Gen. Psychiatry, 67, 692, 10.1001/archgenpsychiatry.2010.81 Williams, H.J., Norton, N., Dwyer, S., Moskvina, V., Nikolov, I., Carroll, L., Georgieva, L., Williams, N.M., Morris, D.W., Quinn, E.M., Giegling, I., Ikeda, M., Wood, J., Lencz, T., Hultman, C., Lichtenstein, P., Thiselton, D., Maher, B.S., Malhotra, A.K., Riley, B., Kendler, K.S., Gill, M., Sullivan, P., Sklar, P., Purcell, S., Nimgaonkar, V.L., Kirov, G., Holmans, P., Corvin, A., Rujescu, D., Craddock, N., Owen, M.J., O'Donovan, M.C., O'Donovan, M.C., 2011. Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder. Mol. Psychiatry 16, 429–441. doi:https://doi.org/10.1038/mp.2010.36. Wittchen, 1997 Yasuda, 2011, Impact on schizotypal personality trait of a genome-wide supported psychosis variant of the ZNF804A gene, Neurosci. Lett., 495, 216, 10.1016/j.neulet.2011.03.069 Zhang, 2011, Evidence of sex-modulated association of ZNF804A with schizophrenia, Biol. Psychiatry, 69, 914, 10.1016/j.biopsych.2011.01.003 Zhang, 2012, The effects of CACNA1C gene polymorphism on spatial working memory in both healthy controls and patients with schizophrenia or bipolar disorder, Neuropsychopharmacology, 37, 677, 10.1038/npp.2011.242